L-aspartic acid, N-(2-(5(6-(aminoiminomethyl)-1H-benzimidazol-2-yl)-5'-(aminosulfonyl)-2',6-dihydroxy(1,1'-biphenyl)-3-yl)acetyl)-,
N-((5-(5-carbamimidoyl-1H-benzimidazol-2-yl)-2',6-dihydroxy-5'-sulfamoyl-3-biphenylyl)acetyl)-L-aspartic acid,
PCI-27483,
PCI-27483,
871266-63-6,
UNII-6073LCU8U9,
6073LCU8U9,
(S)-2-(2-(5-(5-Carbamimidoyl-1H-benzo(d)imidazol-2-yl)-2',6-dihydroxy-5'-sulfamoyl-(1,1'-biphenyl)-3-yl)acetamido)succinic acid,
SCHEMBL1303963,
WDJHHCAKBRKCLW-IBGZPJMESA-N,
AOB87178,
BCP21044,
MFCD25976837,
ZINC43100782,
AKOS030627138,
AKOS032960310,
ZINC136621884,
CS-6692,
DB13000,
SB18729,
PCI27483/PCI-27483,
AS-17004,
HY-16382,
L-Aspartic acid, N-(2-(5-(6-(aminoiminomethyl)-1H-benzimidazol-2-yl)-5'-(aminosulfonyl)-2',6-dihydroxy(1,1'-biphenyl)-3-yl)acetyl)-,
A14368,
Z-3280,
J-690371,
(2S)-2-{2-[3-(6-carbamimidoyl-1H-1,3-benzodiazol-2-yl)-4-hydroxy-5-(2-hydroxy-5-sulfamoylphenyl)phenyl]acetamido}butanedioic acid,
(S)-2-(2-(5-(5-carbamimidoyl-1H-benzo[d]imidazol-2-yl)-2',6-dihydroxy-5'-sulfamoyl-[1,1'-biphenyl]-3-yl)acetamido)succinic aciduinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone,
(S)-2-{2-[5-(5-carbamimidoyl-1H-benzimidazol-2-yl)-6,2'-dihydroxy-5'-sulfamoylbiphenyl-3-yl]acetylamino}succinic acid,
2-Allyl-1-[6-(2-hydroxy-2-propanyl)-2-pyridinyl]-6-{[4-(4-methyl-1-piperazinyl)phenyl]amino}-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin -3-one,
PVTVTDSZGJFYRP-LIAPLOTISA-N,
CID11614097,
CID 11614097,